Influenza vaccination during hospital admission improves survival and reduces readmissions in heart failure patients.
Claims
Influenza vaccination during hospital admission improves survival and reduces readmissions in heart failure patients.
Parent: HealthcareEntity: Influenza VaccinationSub-entity: Heart Failure PatientsImpact: positiveDate: Apr 24, 2026Target: Influenza vaccination during hospital admission improves survival and reduces readmissions in heart failure patients.
The PANDA II trial demonstrates that influenza vaccination has off-target benefits in cardiovascular disease beyond infection prevention.
Parent: Medical ResearchEntity: PANDA II Cluster-Randomised TrialImpact: positiveDate: Apr 24, 2026Target: The PANDA II trial demonstrates that influenza vaccination has off-target benefits in cardiovascular disease beyond infection prevention.
Source posts
[Correspondence] Off-target benefits of influenza vaccination in cardiovascular disease
www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02366-9/fulltext?rss=yes
We read with interest Craig S Anderson and colleagues’ PANDA II cluster-randomised trial of influenza vaccination in heart failure.1 Vaccination during admission improved survival and reduced readmissions at 12 months, with a number needed to vaccinate of…
0 boosts · 0 favs · 0 replies · Apr 24, 2026
[Correspondence] Off-target benefits of influenza vaccination in cardiovascular disease – Authors' reply
www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00705-1/fulltext?rss=yes
We thank Ole Fröbert and colleagues for their interest in our study and proposing that vaccination might protect against cardiovascular disease through mechanisms beyond infection prevention, potentially through immunomodulatory effects. We agree this is…
0 boosts · 0 favs · 0 replies · Apr 24, 2026